Csenge Advisory Group’s Alkermes ALKS Stock Holding History

Csenge Advisory Group’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$3K	–	240
2018 Q3	$3K	Buy	+100	New	+$4.34K	﹤0.01%	673

Other funds holding ALKS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Csenge Advisory Group's ALKS Position: Q4 2018 in Review

Csenge Advisory Group sold out of Alkermes (ALKS) in Q4 2018, closing a stake of 100 shares — an estimated $3K sold.

Csenge Advisory Group first reported a position in ALKS in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 238 funds tracked by Wall St. Rank hold ALKS as of Q4 2018.

Csenge Advisory Group reported no remaining Alkermes position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 100 Alkermes shares in Q4 2018, an estimated $3K.
Csenge Advisory Group first reported a position in Alkermes in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Alkermes position peaked at $3K in Q3 2018.
238 funds tracked by Wall St. Rank held Alkermes as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.